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ABSTRACT A clinically verified patient-specific glucose-insulin metabolic model known as ICING is used to account for time-varying insulin sensitivity. ICING was developed and validated from critically-ill patients with various medical conditions in the intensive care unit in Christchurch Hospital, New Zealand. Hence, it is interesting and vital to analyse the compatibility of the model once fitted to Malaysian critically-ill data. Results were assessed in terms of percentage of model-fit error, both by cohort and per-patient analysis. The ICING model accomplished median fitting error of<1% over data from 63 patients. Most importantly, the median per-patients is at a low fitting error of 0.34% and per cohort is 0.35%. These results provide a promising avenue for near future simulations of developing tight glycaemic control protocol in the Malaysian intensive care unit. 
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INTRODUCTION Critical care units are seeing rapidly growing numbers of patients with hyperglycaemia (high blood glucose) which is similar to diabetes due to endemic insulin resistance as well as the stress of their condition. The metabolic response to stress is characterised by major changes in glucose metabolism. Increased secretion of counter-regulatory hormones leads to a prominent rise in endogenously produced glucose and the rate of hepatic gluconeogenesis, as well as a reduction in insulin sensitivity. An essential treatment of hyperglycaemia in all cases is to maintain active insulin control by monitoring glucose levels and supplying insulin as necessary. In the critical care setting it is even more critical as active control has been shown to reduce mortality by up to 45% [1]. Inhibiting the physiological response to increased glycaemic levels are factors such as increased insulin resistance, absolute or relative insulin deficiency, and drug therapy. Hence, it is vital that normoglycaemia within the intensive care unit (ICU) is maintained.  Hyperglycaemia is not only a marker for severity of illness, it also worsen outcomes, leading to an increased risk of further complications, such as severe infections, myocardial infarctions, polyneuropathy and multiple-organ failure [2]. Done effectively, active insulin control in the ICU reduces organ failure, save lives and reduces cost. However, effective insulin control has proven difficult, particularly within increasingly tight nursing resources as many unit employ less than one nurse per patient. A model-based approach offers the opportunity to improve productivity and enhance the consistency and quality of insulin control to yield successful results [1] Of the prior successful, and many unsuccessful insulin studies studies, none employed computational model-based control to manage the patient’s glycaemic level during or after disaster occurred. Thus, there is significant motivation for effective maintenance of normal glucose levels which have shown potential to provide clinically effective solutions [3–5]. In the ICU, catastrophic disasters may force difficult decisions for intensivist and nurses when demand for round-the-clock care greatly exceeds available resources. Most critical care units routinely function at or near capacity, significantly decreasing available critical care response capabilities for disasters. Current hospitals recognize that excess critical care capacity for a disaster is extremely limited. Critically ill patients often experience physiological stress responses which lead to a highly complex and dynamic metabolic state, making 
effective treatment of hyper-and hypo-glycaemia difficult. Glycaemic variability, and thus poor control, is also independently associated with an increase in mortality. The critical care response to disaster will be challenged and patients care might shift from individually focused to whole group. This study targets to design a model-based approach towards safe management of hyperglycaemia for Malaysian critically-ill patients. However, the focus of this paper is to assess the compatibility of a clinically verified glucose-insulin model with Malaysian critically-ill data. In the first part of this paper, an analysis of the efficacy of current protocol practice is presented. Development of time-varying profiles follows suit as these are used as the critical marker of a patient's metabolic state. The insulin sensitivity metric is independent of both the insulin and nutrition inputs used to derive it. Identifying insulin sensitivity requires capturing the fundamental dynamics of the glucose regulatory system. A clinically verified patient-specific glucose-insulin metabolic model known as ICING [6] is used to account for time-varying insulin sensitivity. ICING [6] was developed and validated from critically-ill patients with various medical conditions in the intensive care unit in Christchurch Hospital, New Zealand. Hence, it is interesting and vital to analyze the compatibility of the model once fitted to Malaysian critically-ill data. Results were assessed in terms of percentage of model-fit error, both by cohort and per-patient analysis. The ICING model [6] accomplished median fitting error of<1% over data from 63 patients. Most importantly, the median per-patients is at a low fitting error of 0.34% and by cohort is 0.35%. These results provide a promising avenue for near future simulations of developing TGC protocol in the Malaysian intensive care unit. 
MATERIALS AND METHODS 
Methodology Data of 63 critically-ill patients were gathered from the intensive care unit of Hospital Tengku Ampuan Afzan Kuantan (HTAA), Pahang. The socio-demographic characteristics and cohort details are summarized in table 1. Malay ethnicity makes the largest cohort at 87% and percentage of male patients is 59%. 67% of patients are under medical category and 67% of patients fall under age cohort of over 50 y old. The Intensive Insulin Protocol used in HTAA to maintain the blood glucose (BG) concentration target was set at 5.1-8.0 mmol/l. Ethics was granted by IIUM Research Ethics Committee and National Institute of Health (NIH). 
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Table 1: Socio-demographic characteristics 
Socio-demographic characteristics Total  N = 63 Gender Female 26 Male 37 Mortality Dead Alive 24 38 Referring Unit Category Neuro 1 Surgical 20 Medical 42 Age groups (years) <29 4 30-39 6 40-49 11 >50 42 Ethnicity Indian 1 Others 3 Chinese 4 Malays 55 
System model The glucose-insulin physiological model used in this study is clinically-validated [6]. Known as ICING model, it uses previous and current BG values, previous nutrition and previous insulin doses to compute the insulin sensitivity, SI of the patient over the previous time period, based on parameter identification algorithm [7] which fits the model to the clinically observed behavior. The resulting time-varying SI profiles represent time-varying metabolic status for individual patients. Model accuracy is assessed by percentage of fitting error, where fitting error is the error between the measured and the modelled blood glucose levels. Testing new interventions with this profile in simulations provides new outputs. Thus, the profile of SI can be used to create “virtual patients” for testing insulin protocols. Virtual simulations for protocol testing will be carried out in future for controller model development. Analysis is done on by cohort which reads the statistics on the possible hourly fitting errors (weighing each hour equally) while per-patient is statistics on each individual patient (weighing each hour equally). Equations (1) to (6) are defined in the nomenclature of table 2.
  
Table 2: ICING equations description 
Symbols Descriptions Symbols Descriptions G(mmol/l) Total plasma glucose VG Glucose distribution volume (L) GE Blood glucose at equilibrium level (mmol/l) P(t)(mmol/min) External nutrition I(mU/l) Plasma insulin α I Saturation plasma insulin disappearance (L/mU) Uex(t)(mU/min) Exogenous insulin input αG Saturation of insulin-simulated glucose removal (L/mU) Q(mU/l) Interstitial insulin d1d2(min-1 Transport rate ) k(min-1 Effective life of insulin in system ) P2(mmol/min) Represent gut PG(min-1 Patient endogenous glucose removal ) D(t)(mmol/min) Dextrose amount from enteral feeding SI(L/mU. min) Interstitial insulin CNS(mmol/min) Uptake central nervous system VI(L) Insulin distribution value nI Diffusion constant insulin between compartment (min-1) P1(mmol/min) Represent stomach nK Kidney clearance rate of insulin from plasma (min-1) PN(t) Parenteral dextrose nL Liver clearance rate of insulin from plasma (min-1) EGP(mmol/min) Production endogenous glucose nC Cellular insulin clearance rate from interstitium (min-1) 
 
Total plasma glucose G(t)=-pG G(t)-SI(G(t)) Q(t)1+αGQ(t) + P(t)+EGPb–CNS VG  ………… (1) 
Interstitial insulin  
𝑄𝑄(𝑡𝑡) =  𝑛𝑛𝑛𝑛�𝑛𝑛(𝑡𝑡) −  𝑄𝑄(𝑡𝑡)� −  𝑛𝑛𝑛𝑛 𝑄𝑄(𝑡𝑡)1+𝛼𝛼𝛼𝛼𝑄𝑄(𝑡𝑡) …………………. (2) 
Plasma insulin   I(t)=-nKI(t)-nL I(t)1+αII(t) -nI(Q(t)+I(t))+ uex(t)VI +(1-xL) uen(G)VI  ……. (3) 
Dextrose  
𝑃𝑃1 =  −𝑑𝑑1𝑃𝑃1 + 𝐷𝐷(𝑡𝑡) …………………………………………… (4)  
𝑃𝑃2 =  −min(𝑑𝑑2𝑃𝑃2,𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃) + 𝑑𝑑1𝑃𝑃1 ……………………. (5)   
𝑃𝑃(𝑡𝑡)  =  𝑃𝑃𝑚𝑚𝑛𝑛(𝑑𝑑2𝑃𝑃2,𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃) + 𝑃𝑃𝑃𝑃(𝑡𝑡)……………………. (6) 
RESULTS AND DISCUSSION Fig. 1 shows the cumulative distribution frequency (CDF) of BG measurement levels for 63 patients undergoing intensive insulin therapy in HTAA, as per cohort (fig. 1a) and per-patient (fig. 1b). The median of BG measurement levels by cohort is at 8.0 mmol/l with an interquartile range of [6.4, 10.1] mmol/l. Fig. 2 shows a random sample of patient profile. The first panel depicts the BG measurement level while the 2nd panel shows the insulin infusion received by the patient. The 3rd
From fig. 1, it can be concluded that 50% of critically-ill patients in the ICU still have unsatisfactory control quality in their BG measurement levels. Half of the patients recorded BG levels above 8 mmol/l even the 
target was set at 5.1-8.0 mmol/l. This drives the motivation to implement a model-based control in a Malaysian ICU setting. Model-based control provides a more systematic approach in the management of hyper glycaemia, more so in a high-occupancy rate ICU. Rather than using the concept of ‘treat’ to meet target, model-based approach ‘prevents’ to safely manage BG within desired level.  Patients in the critical settings have more variable, dynamic and unpredictable BG. By using model-based, patient’s hourly metabolic indicator can be calculated in real-time. Hence, any interventions, for example the amount of insulin or nutrition to be given would be based upon this SI indicator. Therefore, all treatments will be tailored to each patient unlike a one-size fits all method. Sliding-scale insulin protocol as normally seen in a lot of hospital settings uses a standardized care across patients. More often than not, insulin is the only means of control. ICING [6] on the other hand, uses both insulin and nutrition to predict the required BG for the next hour and up to 4hr. Based upon the low percentage of model-fit error, it is promising that ICING [6] model is suitable and relevant to be used for Malaysian critically-ill patients. However, this is a proof of concept and a pilot trial is still needed to validate clinically. This study can be expanded to many other areas. For example, control in high occupancy rate where intervention frequency would be further apart.    and last panel represents the nutrition received and the hourly SI profiles of the patient. SI profiles here are the only metabolic indicator of the patient, an output from ICING model. From this study, 63 SI profiles have been generated. These profiles represent virtual patients which is important for the model-based controller development, an on-going research but not the focus of this paper. In fig. 3, CDF of model fit error for the overall patients fitted to the ICING [6] model is shown. The model achieved a low error at 0.34% per-patient and 0.35% by cohort. 
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Fig. 1b: Per-patient 
Fig. 1: CDF for BG measurement levels (mmol/l) of by cohort and 
per-patient 
 
 
Fig. 2: A random patient profiles receiving intensive insulin therapy 
in a Malaysian ICU setting. Top panel represents the BG 
measurement level (mmol/l) of the patient, 2nd panel shows the 
insulin infusion received (mU/l) during ICU stay, 3rd
 
 panel is the 
nutrition received (mmol/min) and the last panel is the SI profiles 
generated from the ICING model 
 
Fig. 3: Top panel shows the per-patient CDF of percentage model 
fit error (%) of bottom panel gives the by cohort model fit error 
CONCLUSION The intensive glucose-nutrition insulin model, ICING validated in this study with clinical data from a Malaysian ICU setting shows a promising result for model-based control development.  
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